A Phase II, randomized, placebo-controlled, double-blind, multiple dose study to evaluate the Efficacy and Safety of ANB019 in subjects with Palmoplantar Pustulosis.


Register Today!

Trial Information

Start DateFebruary 2020
Lead CRCAdam Pawluch
StatusComplete

For additional information
on this trial contact:

Phone705-566-0005